Peptide ACTH(6-9)-PGP Attenuates the Consequences of Chronic Unpredictable Stress in Male Rats

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Current treatments for major depressive disorder (depression) have significant limitations and there is an urgent need to develop new approaches for antidepressant therapy. Stressful events and hyperactivity of the hypothalamic-pituitary-adrenal (HPA) axis play an important role in the pathogenesis of depression. HPA axis activity is self-regulated by negative feedback loops at several levels, including the negative feedback of the adrenocorticotropic hormone (ACTH). ACTH(6-9) is the amino acid sequence required for activation of ACTH receptors. Here in a chronic unpredictable stress (CUS) model of depression, we investigated the effects of a synthetic PGP-containing analog of this sequence, the peptide ACTH(6-9)-PGP. Adult male Sprague-Dawley rats were daily intraperitoneally injected with saline or ACTH(6-9)-PGP (60 nmol/kg body weight) during the CUS procedure. Administration of ACTH(6-9)-PGP significantly attenuated CUS-induced body weight gain decrease, prevented the decrease in sucrose preference and reduction in hippocampal BDNF levels. The results indicate that in the CUS model, systemically administered ACTH(6-9)-PGP exerts antidepressant-like effects and attenuates the metabolic marker of chronic stress. ACTH(6-9)-PGP can be considered as one of the promising candidates in the development of new pharmacological agents for the treatment and prevention of depression and other stress-related pathologies.

About the authors

O. V. Dolotov

Lomonosov Moscow State University; Kurchatov Institute

Email: dolotovov@my.msu.ru
Moscow, Russia

K. A. Yatsenko

Lomonosov Moscow State University

Moscow, Russia

L. A. Andreeva

Lomonosov Moscow State University

Moscow, Russia

N. F. Myasoedov

Lomonosov Moscow State University

Moscow, Russia

I. A. Grivennikov

Lomonosov Moscow State University

Moscow, Russia

References

  1. Li Z., Ruan M., Chen J., Fang Y. // Neurosci. Bull. 2021. V. 37. P. 863–880.
  2. Chesnut M., Harati S., Paredes P., Khan Y., Foudeh A., Kim J., Bao Z., Williams L.M. // Chronic Stress (Thousand Oaks). 2021. V. 5. P. 24705470211000338.
  3. Menke A. // Frontiers in Psychiatry. 2019. V. 10.
  4. Mikulska J., Juszczyk G., Gawrońska-Grzywacz M., Herbet M. // Brain Sci. 2021. V. 11.
  5. Zunszain P.A., Anacker C., Cattaneo A., Carvalho L.A., Pariante C.M. // Biol. Psychiatry. 2011. V. 35. P. 722–729.
  6. Bao A.M., Meynen G., Swaab D.F. // Brain Res. Rev. 2008. V. 57. P. 531–553.
  7. Tafet G.E., Nemeroff C.B. // Frontiers in Psychiatry. 2020. V. 11. P. 443.
  8. Calogero A.E., Gallucci W.T., Gold P.W., Chrousos G.P. // J. Clin. Invest. 1988. V. 82. P. 767–774.
  9. Sawchenko P.E., Arias C. // J. Neuroendocrinol. 1995. V. 7. P. 721–731.
  10. Markov D.D., Dolotov O.V., Grivennikov I.A. // Int. J. Mol. Sci. 2023. V. 24.
  11. Markov D.D., Yatsenko K.A., Inozemtseva L.S., Grivennikov I.A., Myasoedov N.F., Dolotov O.V. // Psychoneuroendocrinology. 2017. V. 82. P. 173–186.
  12. Willner P. // Neurobiol. Stress. 2017. V. 6. P. 68–77.
  13. Inozemtseva L.S., Yatsenko K.A., Glazova N.Y., Kamensky A.A., Myasoedov N.F., Levitskaya N.G., Grivennikov I.A., Dolotov O.V. // Eur. J. Pharmacol. 2024. V. 984. P. 177068.
  14. Clark A.J., Forfar R., Hussain M., Jerman J., McIver E., Taylor D., Chan L. // Front. Endocrinol. (Lausanne). 2016. V. 7. P. 101.
  15. Mowlazadeh Haghighi S., Zhou Y., Dai J., Sawyer J.R., Hruby V.J., Cai M. // Eur. J. Med. Chem. 2018. V. 151. P. 815–823.
  16. Ashmarin I.P., Nezavibatko V.N., Levitskaya N.G., Koshelev V.B., Kamensky A.A. // Neurosci. Res. Commun. 1995. V. 16. P. 105–112.
  17. Левицкая Н.Г., Глазова Н.Ю., Себенцова Е.А., Манченко Д.М., Андреева Л.А., Каменский А.А., Мясоедов Н.Ф. // Росс. физиол. журн. им. И.М. Сеченова. 2019. Т. 105. С. 761–770.
  18. Dodonova S., Bobyntsev I., Belykh A., Vorvul A. // Research Results in Pharmacology. 2021. V. 7. P. 27–32.
  19. Додонова С.А., Бобынцев И.И., Белых А.Е., Телегина И.А., Музалева Ю.А., Андреева Л.А., Мясоедов Н.Ф. // Росс. физиол. журн. им. И.М. Сеченова. 2020. Т. 106. С. 283–293.
  20. Додонова С.А., Бобынцев И.И., Белых А.Е., Анфилова М.Г., Андреева Л.А., Мясоедов Н.Ф. // Курский научно-практический вестник “Человек и его здоровье”. 2019. С. 84–89.
  21. Vorvul A.O., Bobyntsev, II, Medvedeva O.A., Mukhina A.Y., Svishcheva M.V., Azarova I.E., Andreeva L.A., Myasoedov N.F. // Neuropeptides. 2022. V. 93. P. 102247.
  22. Björkholm C., Monteggia L.M. // Neuropharmacology. 2016. V. 102. P. 72–79.
  23. Colucci-D’Amato L., Speranza L., Volpicelli F. // Int. J. Mol. Sci. 2020. V. 21. P. 7777.
  24. Deyama S., Kaneda K. // Neuropharmacology. 2023. V. 224. P. 109335.
  25. Willner P., Moreau J.L., Nielsen C.K., Papp M., Sluzewska A. // Physiol. Behav. 1996. V. 60. P. 129-134.
  26. Willner P., Towell A., Sampson D., Sophokleous S., Muscat R. // Psychopharmacology (Berl). 1987. V. 93. P. 358-364.
  27. Pollock G.S., Vernon E., Forbes M.E., Yan Q., Ma Y.T., Hsieh T., Robichon R., Frost D.O., Johnson J.E. // J. Neurosci. 2001. V. 21. P. 3923-3931.
  28. Okragly A.J., Haak-Frendscho M. // Exp. Neurol. 1997. V. 145. P. 592-596.
  29. Strekalova T., Liu Y., Kiselev D., Khairuddin S., Chiu J.L.Y., Lam J., Chan Y.-S., Pavlov D., Proshin A., Lesch K.-P., Anthony D.C., Lim L.W. // Psychopharmacology. 2022. V. 239. P. 663-693.
  30. Malta M.B., Martins J., Novaes L.S., Dos Santos N.B., Sita L., Camarini R., Scavone C., Bittencourt J., Munhoz C.D. // Mol. Neurobiol. 2021. V. 58. P. 4871-4885.
  31. Ulrich-Lai Y.M., Figueiredo H.F., Ostrander M.M., Choi D.C., Engeland W.C., Herman J.P. // Am. J. Physiol. Endocrinol. Metab. 2006. V. 291. P. E965-973.
  32. Strekalova T., Gorenkova N., Schunk E., Dolgov O., Bartsch D. // Behav. Pharmacol. 2006. V. 17. P. 271-287.
  33. Strekalova T., Spanagel R., Bartsch D., Henn F.A., Gass P. // Neuropsychopharmacology. 2004. V. 29. P. 2007-2017.
  34. Strekalova T., Steinbusch H.W. // Prog. Neuropsychopharmacol. Biol. Psychiatry. 2010. V. 34. P. 348-361.
  35. Hao Y., Ge H., Sun M., Gao Y. // Int. J. Mol. Sci. 2019. V. 20.
  36. Duman R.S., Deyama S., Fogaça M.V. // Eur. J. Neurosci. 2021. V. 53. P. 126-139.
  37. Mondal A.C., Fatima M. // Int. J. Neurosci. 2019. V. 129. P. 283-296.
  38. Bai Y.-Y., Ruan C.-S., Yang C.-R., Li J.-Y., Kang Z.-L., Zhou L., Liu D., Zeng Y.-Q., Wang T.-H., Tian C.-F., Liao H., Bobrovskaya L., Zhou X.-F. // Neuropsychopharmacology. 2016. V. 41. P. 2882-2892.
  39. Zhang F., Luo J., Min S., Ren L., Qin P. // Brain Res. 2016. V. 1642. P. 43-50.
  40. Rauskolb S., Zagrebelsky M., Dreznjak A., Deograis R., Matsumoto T., Wiese S., Erne B., Sendmer M., Schaeren-Wiemers N., Korte M., Barde Y.A. // J. Neurosci. 2010. V. 30. P. 1739-1749.
  41. Yang J., Harte-Hargrove L.C., Siao C.J., Marinic T., Clarke R., Ma Q., Jing D., Lafrancois J.J., Bath K.G., Mark W., Ballon D., Lee F.S., Scharfman H.E., Hempstead B.L. // Cell Rep. 2014. V. 7. P. 796-806.
  42. Долотов О.В. // Росс. физиол. журн. им. И.М. Сеченова. 2020. T. 106. C. 683-695.
  43. Catania A., Gatti S., Colombo G., Lipton J.M. // Pharmacol. Rev. 2004. V. 56. P. 1-29.
  44. Getting S.J. // Pharmacol. Ther. 2006. V. 111. P. 1-15.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2025 Russian Academy of Sciences

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).